HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Gillette Downsizes Tiger Woods' Marketing Role

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Procter & Gamble/Gillette says it will curtail its use of golf superstar Tiger Woods in promotions

You may also be interested in...



Celebrity Ads Not A Sure Bet; Ace Metrix CEO Discusses Making Them Work

Paying big bucks for a glamorous celebrity to hawk your product may not be worth it, according to research and consulting firm Ace Metrix.

Celebrity Ads Not A Sure Bet; Ace Metrix CEO Discusses Making Them Work

Paying big bucks for a glamorous celebrity to hawk your product may not be worth it, according to research and consulting firm Ace Metrix.

Celebrity Endorsers “Shine A Spotlight” But Bring Costs, Risks

Celebrity endorsers can "create an emotional bridge" between consumers and brands, among other benefits, but they also pose risks and may not be cost-effective.

Table

View full table

Related Content

HBW Insight
HBW Insight
Tags:
Latest Headlines

Probiotics And Cold Remedies Boost Recordati In 2023

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

See All
UsernamePublicRestriction

Register

RS016619

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By